In line with SPARTAN’s vision to accelerate research in the field of Spondyloarthritis and to improve the care of patients with Axial Spondyloarthritis, this seed fund opportunity will support early career investigators who are working in the field of Axial Spondyloarthritis.
The goal is to support the early stages of a research project to generate preliminary data that will support grant applications to funding agencies such as NIH. 2 new grants will be supported (one basic/translational project and one clinical project). A maximum of $10,000 will be allocated per project per year for two years.
Eligibility
– Applicants must be SPARTAN members,
– Within first 5 years of starting their first faculty research position, and
– Appointed at the level of Assistant Professor or Clinical Instructor (not higher)
Application:
Within a maximum of 5 pages, include the following sections in your application.
- Signed Cover Page with Title of the project, applicant contact information and supporting signature of the head of your institution (Research Director or Dean).
- Description – Abstract, Specific Aims, Preliminary results / Supporting Literature and Methods.
- Brief Budget justification (Max 250 words)
- Time line
- Figures and References may be added as appendix (Combined maximum 2 pages)
- BioSketch: Max 5 pages with publications from last 5 years.
- Letter of Support – from the Institution (stating availability of resources and space for the proposed project)
Use of funds
The funds can be used for activities directly linked to the proposal including expendables, services or salary/stipend of fellows or technicians. The funds cannot be used for salary support of the PI. Institutional indirect costs are not supported.
Adjudication
The scientific committee of SPARTAN and the peer review committee for this competition will review applications.
Requirements
Grant recipients must acknowledge SPARTAN in any presentations or publications related to the project. In oral or poster presentations, the SPARTAN logo must be displayed.
Recipients are asked to present their project update at the 2021 annual SPARTAN meeting.
Reporting
A post activity report must be submitted via email to SPARTAN within 6 months of completing each one-year grant period. The study results/progress should be presented at the annual SPARTAN meeting. Reports are mandatory for applicants’ continued participation in future SPARTAN competitions.
Application deadline for the 2022 grants is March 18, 2022
Past Awards
2022
“Characterizing gut microbial dysbiosis in HLA-B27 negative axial spondyloarthritis”
Tejpal Gil, PhD (Oregon Health & Science University)
2021
“Functional Genomics to Identify Key Cellular Drivers in Ankylosing Spondylitis”
Maria Gutierrez-Arcelus, PhD (Boston Children’s Hospital)
“Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn’s Disease: A Pilot Study”
Fardina Malik, MD (NYU Langone School of Medicine)
“Elucidating a Role for Neutrophils in Th17 Immunity and Disease in Ankylosing Spondylitis”
Ruth Napier, PhD (Oregon Health & Science University)
2020
“The impact of tumor necrosis factor inhibitor use on cardiovascular events in ankylosing spondylitis”
Jean Liew, MD (University of Washington)
2019
“The interplay between gender and sex in understanding health quality of life among patients with axial spondyloarthritis: an exploratory sequential mixed method study”
Shao-Hsien Liu, MPH, Ph.D. (University of Massachusetts Medical School)
2018
“Development of Minimal Disease Activity Criteria in Spondyloarthritis”
Maureeen Dubreuil, MD, PhD (Boston University School of Medicine)
“Validation of administrative billing codes for the diagnosis of axial spondyloarthritis”
Jonathan Chan, MD (University of British Columbia, Division of Rheumatology)
2017
“Understanding the pathophysiology of SpA by characterizing trafficking lymphocytes in the gut-joint axis”
Kristi Kuhn, MD, PhD (University of Colorado School of Medicine)
“N-of-1 trials of NSAIDs in SpA with adaptive design”
Runsheng Wang, MD, MHS (Columbia University Medical Center)
